SGS Opens New French Laboratory to Develop its Quality Control Services Throughput and Broaden Capabilities for Biologics
SGS has announced the planned opening of its new bio/pharmaceutical quality control laboratory at Villeneuve La Garenne, a Paris suburb, replacing an existing facility in Clichy. Opening June 29th, 2015, the state-of-the-art laboratory will incorporate the best-in-class infrastructure and equipment to meet the current and future demands of its bio/pharma clients. This multi-million Euro investment will contribute to optimize the sample analysis throughput and support biologics development and will operate under GMP. The 2,100 square meter facility, strategically located near the main logistics hubs, has been designed and built specifically for the needs of the pharmaceutical industry, targeting the reduction of sample processing times through increased operational efficiency.
SGS Completes Expansion and Investment Program at its Facility in Mumbai, India
SGS announced the completion of a major expansion at its Mumbai, India, facility with validation of new equipment currently underway. The expansion has seen the previous 1,393 square meter laboratory space more than double in size, to 3,400 square meters, and, once validation is completed, the laboratory will act as a dedicated cGMP pharmaceutical testing site. The workforce has increased from 65 to 115, with the potential for up to another 40 employees in the additional facilities.
SGS Expands GMP Compliant Solid State Analysis Services at Its Lincolnshire, IL, USA Facility
SGS announced that it has invested in X-Ray Powder Diffraction (XRPD) capabilities at its Lincolnshire, IL, laboratory for solid state analysis. The service, which has been fully qualified and validated, can now be offered to clients wishing to study crystallinity and polymorphism under cGMP conditions.
Read the full press release.
The Medicine Maker Power List 2015
Medicine Maker Magazine’s May edition includes their “Power List” for 2015 – the 100 most influential people in bio/pharma. Who’s on the list? CEO’s of the top bio/pharma companies, Nobel Laureates, the Acting Commissioner of the US-FDA, the two scientists credited for sequencing the human genome and one of SGS’s own scientists, Archie Lovatt.